Intensive cutaneous myiasis due to Musca domestica in a patient with Alzheimer disease: a rare larval infestation in a temperate zone

http://ift.tt/2AniWQI

Paternal gonadal mosaicism as cause of a puzzling inheritance pattern of activated PI3-kinase delta syndrome

Publication date: Available online 6 November 2017
Source:Annals of Allergy, Asthma & Immunology
Author(s): Gesmar R.S. Segundo, Olga A. Takano, Líllian S.L. Moraes, Maria I.S.V. Nadaf, Sergio J. Fernandes, Hans D. Ochs, Troy R. Torgerson




http://ift.tt/2y7KaJE

Bee moth (Galleria mellonella) allergy

Publication date: Available online 6 November 2017
Source:Annals of Allergy, Asthma & Immunology
Author(s): Andrea Antico, Mara Vegro, Giuseppe Rasio, Gabriella Pasini, Andrea Curioni




http://ift.tt/2zjkRFK

Association of consistently suboptimal quality of life with consistently poor asthma control in children with asthma

Publication date: Available online 6 November 2017
Source:Annals of Allergy, Asthma & Immunology
Author(s): Carrie R. Howell, Lindsay A. Thompson, Heather E. Gross, Bryce B. Reeve, Shih-Wen Huang, Darren A. DeWalt, I-Chan Huang




http://ift.tt/2y7JSCy

Forced expiratory values in 1 second corresponding to Pediatric Respiratory Assessment Measure and Acute Asthma Intensity Research Score values during pediatric acute asthma exacerbations

Publication date: Available online 6 November 2017
Source:Annals of Allergy, Asthma & Immunology
Author(s): Donald H. Arnold, David P. Johnson, Connie L. Yang, Tina V. Hartert




http://ift.tt/2zlgmL5

What can we learn in drug allergy management from World Health Organization's International Classifications?

Abstract

Drug hypersensitivity reactions (DHRs) represent growing health problem worldwide, affecting more than 7% of the general population and represent an important public health problem. However, knowledge in DHRs morbidity and mortality epidemiological data is still not optimal and international comparable standards remain poorly accessed. Institutional databases worldwide increasingly use the WHO International Classification of Diseases (ICD) system to classify diagnoses, health services utilization and death data. The misclassification of disorders in the ICD system contributes to a lack of ascertainment and recognition of their importance for healthcare planning and resource allocation. It also hampers clinical practice and prevention actions.

To further inform the allergy community and to ensure that the revision process is transparent as advised in the WHO ICD-11 revision agenda, we report the advances and use of the pioneering "Drug hypersensitivity" subsection of ICD-11 and implementation in the WHO International Classification of Health Interventions (ICHI). The new classification addressed to DHRs will enable the collection of more accurate epidemiological data to support quality management of patients with drug allergies, and better facilitate health care planning and decision-making and public health measures to prevent and reduce the morbidity and mortality attributable to DHRs.

This article is protected by copyright. All rights reserved.

http://ift.tt/2lVEIrE

Economic evidence for non-pharmacological asthma management interventions: A systematic review

Abstract

Asthma management, education and environmental interventions have been reported as cost effective in a previous review, (Yong and Shafie et al, 2014), but methods used to estimate costs and outcomes were not discussed in detail. This review updates the previous review by providing economic evidence on the cost effectiveness of studies identified after 2012, and a detailed assessment of the methods used in all identified studies. Twelve databases were searched from 1990 to January 2016, and studies included economic evaluations, asthma subjects, and non-pharmacological interventions written in English. Sixty-four studies were included. Of these, fifteen were found in addition to the earlier review; 53% were rated fair in quality and 47% high. Education and self-management interventions were the most cost effective, in line with the earlier review. Self-reporting was the most common method used to gather resource use data, accompanied with bottom-up approaches to estimate costs. Main outcome measures were asthma-related hospitalizations (69%), quality of life (41%) and utility (38%), with AQLQ and the EQ-5D being the most common questionnaires measured prospectively at fixed time points. More rigorous costing methods are needed with a more common quality of life tool to aid greater replicability and comparability amongst asthma studies.

This article is protected by copyright. All rights reserved.

http://ift.tt/2yA3VO6